Merck & Co. Inc. (NYSE: MRK) is rewarding its shareholders once again with a quarterly dividend of $0.81 per share, payable ...

Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture, and commercialize HRS-5346 worldwide, excluding the Greater China region. Hengrui Pharma will ...

US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking as he announced 25% tariffs on cars and car parts imported into the US.

Data on federal individual contributions downloaded from the Federal Election Commission on 02/06/2025. State and local contributions are uploaded on a rolling basis. Federal law prohibits the use of ...

Spurious drug manufacturers from other states are tarnishing the image of state’s pharmaceutical industry by using fictitious names of firms located in Himachal Pradesh. A recent case which ...

Rahway: Merck, known as MSD outside of the United States and Canada, and Jiangsu Hengrui Pharmaceuticals Co., Ltd., a global pharmaceutical company focused on scientific and technological innovation, ...

(Image Credits: Pixabay ... Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region.

Check out the image below, which I created and downloaded with Reve Image. It looks like a real photo of a woman engaged in some sort of conflict in a snowy setting. I know, it’s strange ...

However, gains were capped as investors booked profits following last week’s sharp rally, while PSU bank and pharma stocks weighed on sentiment. The broader market showcased weak trends ...

Last year Merck agreed a similar licensing deal, also worth $2 billion, for Chinese biotech Hansoh Pharma’s experimental oral obesity drug, while yesterday Denmark’s Novo Nordisk (NVO ...